Compare Johnson & Johnson (JNJ) vs Global X Lithium & Battery Tech ETF (LIT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs Global X Lithium & Battery Tech ETF — how do they compare? Johnson & Johnson trades at $260.51 (market cap $626.09B), while Global X Lithium & Battery Tech ETF trades at $75.58. The key difference: Johnson & Johnson pays a 2.06% dividend while Global X Lithium & Battery Tech ETF pays none, and Johnson & Johnson is trading nearer its 52-week high, Global X Lithium & Battery Tech ETF nearer its low. Which is the better fit depends on your goals.
| JNJ | LIT | |
|---|---|---|
Market Cap | $626.09B | — |
Volume | 6,156,228 | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $267.24 | $91.62 |
52-Week Low | $172.78 | $44.96 |
Enterprise Value | $654.37B | — |
Dividend Yield | 2.06% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $260.88, down 0.36% today, with a bullish technical signal supported by moving averages. The stock shows strong profitability with a net margin of 21.48% and ROE of 25.74%, though valuations like a P/E of 30.14 appear elevated. Recent earnings beat expectations in Q1 and Q2 2026, and the company maintains a 64-year dividend growth streak, with analyst consensus leaning bullish.
Outlook remains positive with a consensus price target of $284.50, offering potential upside, but risks include legal challenges and high debt-to-asset ratio of 24.06% in 2025. Investors benefit from steady dividends and defensive positioning in healthcare, though valuation multiples may limit near-term gains amid economic uncertainty.
LIT trades at $75.21, up 0.63% on the day, with a bullish technical signal from moving averages and oscillators. Recent news highlights strong momentum in the lithium and battery tech sector, driven by EV demand growth and China's 2030 NEV target. The stock has doubled over the past year, reflecting a rebound in lithium markets and positive sentiment around energy storage and semiconductor applications.
Outlook remains positive given sector tailwinds, but risks include reliance on EV adoption rates and potential oversupply. The stock's technical overbought condition near resistance at $75 suggests near-term consolidation may occur. Long-term growth is tied to global electrification trends and lithium market dynamics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About Global X Lithium & Battery Tech ETF
LIT invests in the full lithium cycle, from mining and refining to battery production and EV manufacturing. It tracks the Solactive Global Lithium Index, with top holdings including Rio Tinto, Albemarle, and Tesla, as well as major battery makers like Samsung SDI.
Read more on LIT →
